Cargando…

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study

BACKGROUND: Anemia is relatively common in cancer patients, and baseline anemia is associated with poor survival in patients with non-small cell lung cancer (NSCLC). However, there is a lack of large-sample studies of patients with NSCLC with epidermal growth factor receptor (EGFR) mutations. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jingwen, Xiang, Jing, Hao, Yue, Si, Jinfei, Wang, Wenxian, Li, Fangyin, Song, Zhengbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575199/ https://www.ncbi.nlm.nih.gov/pubmed/36253772 http://dx.doi.org/10.1186/s12890-022-02158-w

Ejemplares similares

Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
por: Si, Jinfei, et al.
Publicado: (2023)

Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer
por: Chen, Cheng, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
por: Xiang, Jing, et al.
Publicado: (2023)

Comparison of efficacy and safety of second‐ and third‐generation TKIs for non‐small‐cell lung cancer with uncommon EGFR mutations
por: Hao, Yue, et al.
Publicado: (2023)

The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
por: Guan, Yelan, et al.
Publicado: (2023)

Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma
por: Hao, Yue, et al.
Publicado: (2022)

Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinoma
por: Wei, Jingwen, et al.
Publicado: (2023)

The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study
por: Yu, Xiaoqing, et al.
Publicado: (2022)

Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer
por: Xu, Manyi, et al.
Publicado: (2023)

Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
por: Gu, Xiaodong, et al.
Publicado: (2023)

Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer
por: Xu, Yi-Bing, et al.
Publicado: (2021)

Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis
por: Wang, Wenxian, et al.
Publicado: (2018)

Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients
por: Zhou, Huan, et al.
Publicado: (2023)

The effect of anemia on the severity and prognosis of patients with acute pancreatitis: A single-center retrospective study
por: Cai, Ying-Li, et al.
Publicado: (2022)

The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis
por: Guan, Yelan, et al.
Publicado: (2023)

Association of Severe Thrombocytopenia and Poor Prognosis in Pregnancies with Aplastic Anemia
por: Shin, Jae Eun, et al.
Publicado: (2014)

DEAD-box helicase 27 enhances stem cell-like properties with poor prognosis in breast cancer
por: Li, Shan, et al.
Publicado: (2021)

Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study
por: Wang, Wenxian, et al.
Publicado: (2018)

Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
por: Wang, Wenxian, et al.
Publicado: (2022)

Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
por: Wang, Wenxian, et al.
Publicado: (2016)

Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers
por: Song, Zhengbo, et al.
Publicado: (2020)

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer
por: Swinson, D E B, et al.
Publicado: (2004)

Poor prognosis of urothelial carcinoma in patients presented with persistent paraneoplastic leukocytosis with anemia
por: Warli, Syah Mirsya, et al.
Publicado: (2022)

Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
por: Chen, Zhan-hong, et al.
Publicado: (2018)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors
por: Fu, Yang, et al.
Publicado: (2020)

Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations
por: Wang, Yue, et al.
Publicado: (2020)

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study
por: Gu, Xiaodong, et al.
Publicado: (2022)

Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations
por: Kang, Hye Seon, et al.
Publicado: (2020)

The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis
por: Wei, Wei, et al.
Publicado: (2023)

Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients
por: Tezcan, M.E., et al.
Publicado: (2020)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients
por: Shimizu, Katsuhiko, et al.
Publicado: (2012)

Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
por: Bai, Ming, et al.
Publicado: (2022)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
por: Portolés, José, et al.
Publicado: (2013)

HIV-Associated Tuberculosis: Does the Iron-Regulatory Hormone Hepcidin Connect Anemia With Poor Prognosis?
por: Armitage, Andrew E., et al.
Publicado: (2016)

Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study
por: Wei, Jingwen, et al.
Publicado: (2023)

High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer
por: Oh, Jinju, et al.
Publicado: (2014)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fn6bq2nbddt0rb1t97u8fmq8d3